Adamis Pharmaceuticals Corp Purchase Agreements
18 Contracts & Agreements
- Securities Purchase Agreement (Filed With SEC on August 3, 2023)
- Purchase and Sale Agreement (Filed With SEC on July 24, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on July 13, 2023)
- Securities Purchase Agreement dated March 14, 2023 (Filed With SEC on May 15, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on March 14, 2023)
- Securities Purchase Agreement, dated July 5, 2022, between Adamis Pharmaceuticals Corporation and the parties thereto (Filed With SEC on July 6, 2022)
- Asset Purchase Agreement effective as of July 30, 2021, by and among the Registrant, US Compounding, Inc. and Fagron Compounding Services, LLC (Filed With SEC on August 5, 2021)
- Form of Securities Purchase Agreement (Filed With SEC on February 21, 2020)
- Form of Securities Purchase Agreement dated July 29, 2016 (Filed With SEC on July 29, 2016)
- Purchase Agreement dated as of July 11, 2016 (Filed With SEC on July 12, 2016)
- Purchase Agreement dated as of January 26, 2016 (Filed With SEC on January 26, 2016)
- Purchase Agreement dated as of August 19, 2014 (Filed With SEC on August 20, 2014)
- 3,720,000 Shares Adamis Pharmaceuticals Corporation PURCHASE AGREEMENT (Filed With SEC on December 17, 2013)
- Exclusive License and Asset Purchase Agreement dated as of August 1, 2013, by and among the Company, 3M Corp. and 3M Innovative Properties Company (Filed With SEC on August 6, 2013)
- Securities Purchase Agreement dated as of April 5, 2013 (Filed With SEC on April 8, 2013)
- Securities Purchase Agreement dated as of June 11, 2012 (Filed With SEC on June 15, 2012)
- Securities Purchase Agreement dated as of April 2, 2012 (Filed With SEC on April 5, 2012)
- Securities Purchase Agreement dated as of January 11, 2010 (Filed With SEC on January 15, 2010)
